ARTV
ARTIVA BIOTHRP (ARTV)
NASDAQ
$6.89+$0.02 (+0.28%)
Price as of Jun 03, 2026 6:59 PM EDT
  • $385.3M
    Market Cap
  • 252.31%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
0
-100.00%
251,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
0
-100.00%
251,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-76,000
-97.60%
-3.2M
N/A
Depreciation and Amortization Expense
2.6M
+6.83%
2.4M
N/A
Total Operating Expenses
89.8M
+32.99%
67.5M
N/A
Operating Profit
-89.8M
+33.48%
-67.3M
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
Total Nonoperating Income and Expense
5.9M
+211.42%
1.9M
N/A
Income before Taxes
-89.8M
+37.38%
-65.4M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
0
N/A
0
N/A
Net Income
-83.9M
+28.29%
-65.4M
N/A
Net Income from Continuing Operations Applicable to Common
-83.9M
+28.29%
-65.4M
N/A
Basic EPS and Net Income
-3.43
-40.96%
-5.81
N/A
Diluted EPS and Net Income
-3.43
-40.96%
-5.81
N/A
Basic Weighted Average Shares
24.4M
+117.11%
11.3M
N/A
Diluted Weighted Average Shares
24.4M
+117.11%
11.3M
N/A
Balance Sheet
Cash and Cash Equivalents
26.7M
-33.64%
40.2M
N/A
Short-Term Investments
81.3M
-44.00%
145.2M
N/A
Cash and Cash Equivalents and Short-Term Investments
108.0M
-41.75%
185.4M
N/A
Total Current Assets
112.7M
-40.27%
188.6M
N/A
Accumulated Depreciation
8.5M
+42.78%
5.9M
N/A
Property and Plant and Equipment and Net
6.6M
+3.89%
6.4M
N/A
Total Long-Term Assets
458,000
+71.54%
267,000
N/A
Total Assets
130.9M
-37.52%
209.6M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
13.1M
+6.81%
12.3M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
73,000
0.00%
73,000
N/A
Total Liabilities
21.0M
-8.59%
22.9M
N/A
Retained Earnings
-330.5M
+34.00%
-246.7M
N/A
Total Stockholders Equity
110.0M
-41.08%
186.6M
N/A
Total Shares Outstanding
24.3M
0.00%
24.3M
N/A
Cash Flow
Cash from Operating Activities
-76.8M
+39.47%
-55.0M
N/A
Capital Expenditures
2.6M
+302.96%
642,000
N/A
Cash from Investing Activities
63.4M
+152.64%
-120.5M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
9,000
-99.99%
162.2M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-49.26%
N/A
N/A
N/A
Return on Equity
-56.55%
N/A
N/A
N/A
Revenue Growth
-100.00%
N/A
N/A
N/A
Current Ratio
8.61
N/A
N/A
N/A
Cash Ratio
2.04
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow